Actinium Pharmaceuticals, Inc.
ATNM
$1.27
$0.043.25%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 35.00M | -- | 0.00 | 90.00K | -- |
| Total Revenue | 35.00M | -- | 0.00 | 90.00K | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 35.00M | -- | 0.00 | 90.00K | -- |
| SG&A Expenses | 2.06M | 1.70M | 2.12M | 1.53M | 2.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.44M | 5.90M | 6.41M | 5.78M | 7.50M |
| Operating Income | 27.57M | -5.90M | -6.41M | -5.69M | -7.50M |
| Income Before Tax | 27.90M | -5.52M | -5.94M | -5.13M | -6.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 27.90M | -5.52M | -5.94M | -5.13M | -6.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.90M | -5.52M | -5.94M | -5.13M | -6.88M |
| EBIT | 27.57M | -5.90M | -6.41M | -5.69M | -7.50M |
| EBITDA | 28.00M | -5.87M | -6.37M | -5.49M | -7.14M |
| EPS Basic | 0.89 | -0.18 | -0.19 | -0.16 | -0.22 |
| Normalized Basic EPS | 0.56 | -0.11 | -0.12 | -0.10 | -0.14 |
| EPS Diluted | 0.89 | -0.18 | -0.19 | -0.16 | -0.22 |
| Normalized Diluted EPS | 0.56 | -0.11 | -0.12 | -0.10 | -0.14 |
| Average Basic Shares Outstanding | 31.40M | 31.24M | 31.20M | 31.20M | 31.20M |
| Average Diluted Shares Outstanding | 31.41M | 31.24M | 31.20M | 31.20M | 31.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |